Lista de obras - F Delhommeau - Dominio Público Uruguay

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

artículo científico publicado en 2005

Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms

scientific article published on 29 June 2009

Applying ecological and evolutionary theory to cancer: a long and winding road ⬇️

artículo científico publicado en 2012

Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism

artículo científico publicado en 2017

Clonal architecture of chronic myelomonocytic leukemias

artículo científico publicado en 2013

Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy

artículo científico publicado en 2020

Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation.

artículo científico publicado en 2016

Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis.

artículo científico publicado en 2006

Elliptocytosis in patients with C-terminal domain mutations of protein 4.1 correlates with encoded messenger RNA levels rather than with alterations in primary protein structure.

artículo científico publicado en 2000

Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis.

artículo científico publicado en 2006

Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera ⬇️

artículo científico publicado el 27 de enero de 2011

Genetic Hierarchy of Acute Myeloid Leukemia: From Clonal Hematopoiesis to Molecular Residual Disease

artículo científico publicado en 2018

Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders

artículo científico publicado en 2006

Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.

artículo científico publicado en 2016

Interest of cytogenetic and FISH evaluation for prognosis evaluation in 198 patients with acute myeloid leukemia in first complete remission in a single institution

artículo científico publicado en 2014

Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia.

artículo científico publicado en 2016

JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines.

artículo científico publicado en 2014

Macrophage migration inhibitory factor is overproduced through EGR1 in TET2<sup>low</sup> resting monocytes

artículo científico publicado en 2022

Measurement of telomere length on tissue sections using quantitative fluorescencein situ hybridization (Q-FISH)

scientific article published on 01 August 2003

Molecular aspects of myeloproliferative neoplasms.

artículo científico publicado en 2010

Mutations du gèneTET2dans les hémopathies myéloïdes humaines

article

Natural history of hereditary spherocytosis during the first year of life

scientific article published on 01 January 2000

New mutations and pathogenesis of myeloproliferative neoplasms.

artículo científico publicado en 2011

Nonsense-mediated mRNA decay (NMD) blockage promotes nonsense mRNA stabilization in protein 4.1R deficient cells carrying the 4.1R Coimbra variant of hereditary elliptocytosis ⬇️

artículo científico publicado el 21 de septiembre de 2010

Oncogenic kinases of myeloproliferative disorders induce both protein synthesis and G1 activators

artículo científico publicado en 2006

Persistent maternal viremia after varicella infection during pregnancy as a possible cause of false positive prenatal diagnosis of fetal infection on amniotic fluid

artículo científico publicado en 2004

Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia

artículo científico publicado en 2017

Primary plasma cell leukemia mimicking an adult T-cell leukemia-lymphoma: a case report.

artículo científico publicado en 2010

Protein 4.1R expression in normal and dystrophic skeletal muscle.

artículo científico publicado en 2005

Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis.

artículo científico publicado en 2000

Reed Sternberg cell/lymphocyte rosettes in a bone marrow aspirate leading to the diagnosis of Hodgkin lymphoma.

artículo científico publicado en 2016

Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death.

artículo científico publicado en 2003

Role of TET2 mutations in myeloproliferative neoplasms

artículo científico publicado en 2012

Sensitivity to Radiation and Alkylating Agent of Peripheral Lymphocytes and Fibroblasts in a Hoyeraal-Hreidarsson Syndrome Patient ⬇️

artículo científico publicado el 1 de diciembre de 2003

TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis

TET2 deficiency inhibits mesoderm and hematopoietic differentiation in human embryonic stem cells.

artículo científico publicado en 2014

TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis

scientific journal article

TP53 mutations: the dawn of Shwachman clones

artículo científico publicado en 2018

Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant

artículo científico publicado en 2002

Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.

artículo científico publicado en 2007

The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera

artículo científico publicado en 2007

The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues

artículo científico publicado en 2011

The cell cycle regulator CDC25A is a target for JAK2V617F oncogene.

artículo científico publicado en 2011

The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity

scientific article published on 08 July 2008

Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.

artículo científico publicado en 2009

Lista de obras de F Delhommeau

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms

Applying ecological and evolutionary theory to cancer: a long and winding road ⬇️

Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism

Clonal architecture of chronic myelomonocytic leukemias

Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy

Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation.

Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis.

Elliptocytosis in patients with C-terminal domain mutations of protein 4.1 correlates with encoded messenger RNA levels rather than with alterations in primary protein structure.

Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis.

Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera ⬇️

Genetic Hierarchy of Acute Myeloid Leukemia: From Clonal Hematopoiesis to Molecular Residual Disease

Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders

Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.

Interest of cytogenetic and FISH evaluation for prognosis evaluation in 198 patients with acute myeloid leukemia in first complete remission in a single institution

Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia.

JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines.

Macrophage migration inhibitory factor is overproduced through EGR1 in TET2<sup>low</sup> resting monocytes

Measurement of telomere length on tissue sections using quantitative fluorescencein situ hybridization (Q-FISH)

Molecular aspects of myeloproliferative neoplasms.

Mutations du gèneTET2dans les hémopathies myéloïdes humaines

Natural history of hereditary spherocytosis during the first year of life

New mutations and pathogenesis of myeloproliferative neoplasms.

Nonsense-mediated mRNA decay (NMD) blockage promotes nonsense mRNA stabilization in protein 4.1R deficient cells carrying the 4.1R Coimbra variant of hereditary elliptocytosis ⬇️

Oncogenic kinases of myeloproliferative disorders induce both protein synthesis and G1 activators

Persistent maternal viremia after varicella infection during pregnancy as a possible cause of false positive prenatal diagnosis of fetal infection on amniotic fluid

Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia

Primary plasma cell leukemia mimicking an adult T-cell leukemia-lymphoma: a case report.

Protein 4.1R expression in normal and dystrophic skeletal muscle.

Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis.

Reed Sternberg cell/lymphocyte rosettes in a bone marrow aspirate leading to the diagnosis of Hodgkin lymphoma.

Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death.

Role of TET2 mutations in myeloproliferative neoplasms

Sensitivity to Radiation and Alkylating Agent of Peripheral Lymphocytes and Fibroblasts in a Hoyeraal-Hreidarsson Syndrome Patient ⬇️

TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis

TET2 deficiency inhibits mesoderm and hematopoietic differentiation in human embryonic stem cells.

TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis

TP53 mutations: the dawn of Shwachman clones

Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant

Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.

The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera

The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues

The cell cycle regulator CDC25A is a target for JAK2V617F oncogene.

The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity

Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.